Vitamin D reduces risk of kidney cancer, finds study
China: Higher intake of dietary vitamin D and higher circulating vitamin D may reduce the risk of renal cell carcinoma (RCC), suggests a recent study in the International Brazilian Journal of Urology.
Renal cell carcinoma is the most common form of kidney cancer with an estimated 65,340 new diagnosis and leading to 14,970 deaths in 2017 in the United States. Despite significant advances in RCC treatment, the prognosis remains poor, and the mortality rate remains high.
Wu J, Harbin Medical University, Harbin, China, and colleagues aimed to evaluate the associations of circulating and dietary intake of vitamin D with risk of renal cell carcinoma.
For the purpose, they searched the online databases from their inception through December 2018. The Newcastle-Ottawa scale was employed to assess the quality of the included studies. This meta-analysis included a total of 9 publications.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.